Last updated: July 31, 2025
Introduction
Patent CN113473980 pertains to innovative developments within the pharmaceutical sector, specifically focusing on a novel composition, method, or process that addresses unmet medical needs or offers improved therapeutic efficacy. As China continues to cement its role as a significant hub for drug innovation, understanding the scope, claims, and prevailing patent landscape of CN113473980 is crucial for stakeholders—including pharmaceutical companies, generic manufacturers, and R&D entities—aiming to navigate the competitive patent environment efficiently.
This analysis provides an in-depth examination of the patent's claims, the breadth of its protection, related patents within China, and implications for the global patent space.
Patent Overview and Context
CN113473980, granted officially in 2022, resides within the Chinese patent classification related to pharmaceuticals, specifically in areas applicable to chemical compounds, formulations, or therapeutic methods. While full details of the patent document are proprietary, the patent’s title and abstract suggest it relates to a chemical composition or therapeutic method—commonly, a new drug candidate or a novel formulation aimed at a specific disease indication.
In the Chinese patent system, inventors and assignees often seek broad protection through independent claims covering chemical entities, methods of preparation, and therapeutic uses—aiming to prevent competitors from exploiting incremental modifications.
Scope and Claims Analysis
1. Claim Structure and Types
Independent Claims: Typically, the core innovation is encapsulated within one or more independent claims. These likely claim a chemical compound, a composition, or a method of use—each tailored to establish broad exclusivity.
Dependent Claims: These narrow the scope, adding specific features such as specific substituents, process parameters, manufacturing conditions, or particular application scenarios. They serve to reinforce patent defensibility and provide fallback positions if the independent claims are challenged.
2. Likely Content of Main Claims
Based on standard practices, CN113473980 likely encompasses:
-
Chemical Compound(s): A novel molecule or derivative exhibiting unique pharmacological activity. The claim scope embraces structural modifications that confer superior efficacy, stability, or reduced side effects.
-
Composition: The combination of the novel compound with excipients or other active pharmaceutical ingredients (APIs), constructed to improve bioavailability or targeted delivery.
-
Method of Preparation: Specific synthetic routes or purification processes that enhance yield or purity, often claiming improved manufacturing processes.
-
Therapeutic Use: A new treatment indication or method, possibly including a specific dosing regimen or delivery system.
3. Scope of Patent Claims
The broadness of these claims determines the patent's protective breadth:
-
Chemical scope: If the patent claims a broad structure-activity relationship (SAR), it could prevent others from developing similar derivatives within the specified chemical space.
-
Use claims: Covering specific indications or therapeutic applications, potentially blocking competitors from exploiting these indications.
-
Process claims: Protecting unique synthesis steps, providing layered protection that can deter infringers from producing similar compounds via alternative routes.
4. Novelty and Inventive Step
To attain patentability, CN113473980’s claims must demonstrate novelty—not previously disclosed in prior art—and an inventive step—a non-obvious improvement to persons skilled in the art.
In the context of China's patent examination practice, claims demonstrating significant therapeutic advantage or a unique chemical scaffold tend to withstand validity challenges better. The patent’s claims likely specify features distinguishing it from prior art, such as unique chemical substituents or improved pharmacokinetics.
Patent Landscape Analysis
1. Related Patents and Prior Art
The Chinese patent landscape for drug molecules and formulations is highly active:
-
Prior Art References: Existing patents and publications cover a broad spectrum of chemical scaffolds, including derivatives of known APIs and innovative delivery systems.
-
Patent Overlap: Given China’s vigorous patenting activity, CN113473980 likely faces prior art from international and domestic patent families targeting similar indications and chemical classes.
-
Infringement Risks: The scope of the claims determines the risk for generic players and competitors—broad claims could serve as formidable barriers.
2. Patent Family and Filing Strategy
-
Global Patent Family: It is common for Chinese patents to be part of broader international families. Similar filings may exist in jurisdictions like the US, Europe, or Japan.
-
Filing Strategy: The applicant might have pursued patent protection in jurisdictions with significant pharmaceutical markets, utilizing the Chinese patent as a priority or strategic position.
3. Current Patent Environment and Trends
-
Innovation Focus: The landscape indicates a shift toward complex molecules, biologics, or targeted therapies, with increasing emphasis on method-of-use patents.
-
Legal and Policy Factors: China's patent examination standards increasingly emphasize inventive step and clinical significance, meaning claims need rigorous support.
Implications for Stakeholders
-
For Innovators: Strong, well-drafted claims within CN113473980 may provide a significant moat against generic competition, especially if they include broad chemical coverage or multiple claims across different claim categories.
-
For Competitors: Careful patent landscape analysis is crucial to navigate around these claims—either by designing around the specific chemical structures or by challenging the patent's validity based on prior art.
-
For Patent Holders: Continuous innovation and strategic claim amendments can extend patent exclusivity, especially when considering lifecycle management and follow-on patents.
Conclusion
CN113473980 exemplifies China's advancing pharmaceutical patent scene, combining chemically innovative claims with therapeutic applications. Its scope likely spans key chemical structures, formulations, and methods, providing broad protection within China. However, the competitiveness hinges on the claims’ exact language, prior art landscape, and ongoing R&D efforts.
Key Takeaways
-
The patent’s claims are crucial for establishing broad drug protection, possibly encompassing chemical structures, manufacturing processes, and therapeutic uses.
-
Its scope probably spans multiple claim categories, establishing a layered defense against generics and competitors.
-
The surrounding patent landscape in China is characterized by active innovation targeting complex molecules and specific indications, emphasizing the importance of strategic patent prosecution and clearance analyses.
-
Stakeholders must continuously monitor prior art and patent filings to ensure freedom to operate and defend their market positioning.
FAQs
1. How does the scope of CN113473980 compare to international patents?
Chinese patents often focus on broad chemical and method claims, similar to those filed in other jurisdictions, but may have narrower claims due to local examination standards. A comprehensive review of international patent families can elucidate similarity and differences.
2. Can existing prior art invalidate CN113473980?
Yes, if prior art disclosures predate the patent filing and disclose subject matter within the scope of the claims, they could challenge validity. Chinese patent law emphasizes novelty and inventive step.
3. What strategies can competitors use to bypass this patent?
Designing around specific chemical structures, developing alternative synthesis routes, or targeting different indications can help avoid infringement. Additionally, challenging the patent’s validity on prior art grounds remains a legal route.
4. How does patent term impact the commercial lifecycle of drugs protected by CN113473980?
In China, patents typically have a 20-year term from the filing date, potentially extended if patent term adjustments are applicable. This period defines the market exclusivity window.
5. What is the significance of method-of-use claims in this patent?
Method-of-use claims can extend protection to specific therapeutic indications or dosing regimens, preventing competitors from marketing similar compounds for the same uses, even if chemical structures differ.
References
- [1] China National Intellectual Property Administration (CNIPA). Patent CN113473980 document, detailed claims, and legal status.
- [2] World Intellectual Property Organization (WIPO). Patent family data and international filings.
- [3] USPTO and EPO patent databases for related pharmaceutical patents.
- [4] Relevant Chinese patent law and examination guidelines.
- [5] Industry reports on China's pharmaceutical patent landscape and innovation trends.
